BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19903104)

  • 1. Efficient clinical-scale enrichment of lymphocytes for use in adoptive immunotherapy using a modified counterflow centrifugal elutriation program.
    Powell DJ; Brennan AL; Zheng Z; Huynh H; Cotte J; Levine BL
    Cytotherapy; 2009; 11(7):923-35. PubMed ID: 19903104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte enrichment from leukapheresis products by using the Elutra cell separator.
    Kim S; Kim HO; Baek EJ; Choi Y; Kim HS; Lee MG
    Transfusion; 2007 Dec; 47(12):2290-6. PubMed ID: 17764512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large scale isolation of human blood monocytes by continuous flow centrifugation leukapheresis and counterflow centrifugation elutriation for adoptive cellular immunotherapy in cancer patients.
    Faradji A; Bohbot A; Schmitt-Goguel M; Siffert JC; Dumont S; Wiesel ML; Piemont Y; Eischen A; Bergerat JP; Bartholeyns J
    J Immunol Methods; 1994 Sep; 174(1-2):297-309. PubMed ID: 8083534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient elutriation of monocytes within a closed system (Elutra) for clinical-scale generation of dendritic cells.
    Berger TG; Strasser E; Smith R; Carste C; Schuler-Thurner B; Kaempgen E; Schuler G
    J Immunol Methods; 2005 Mar; 298(1-2):61-72. PubMed ID: 15847797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective clinical-scale production of dendritic cell vaccines by monocyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection.
    Erdmann M; Dörrie J; Schaft N; Strasser E; Hendelmeier M; Kämpgen E; Schuler G; Schuler-Thurner B
    J Immunother; 2007 Sep; 30(6):663-74. PubMed ID: 17667530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of monocytes from cryopreserved mobilized apheresis products by elutriation with the Elutra device.
    Lemarie C; Sugaye R; Kaur I; Taga T; Chabannon C; Schuyler R; Mcmannis J
    J Immunol Methods; 2007 Jan; 318(1-2):30-6. PubMed ID: 17129586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a closed-system process for clinical-scale generation of DCs: evaluation of two monocyte-enrichment methods and two culture containers.
    Wong EC; Lee SM; Hines K; Lee J; Carter CS; Kopp W; Bender J; Read EJ
    Cytotherapy; 2002; 4(1):65-76. PubMed ID: 11953043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of Cobe AutoPBSC and Gambro Elutra as a platform for monocyte enrichment in dendritic cell (DC) therapy: clinical study.
    Chen Y; Hoecker P; Zeng J; Dettke M
    J Clin Apher; 2008; 23(5):157-62. PubMed ID: 18712854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical-scale elutriation as a means of enriching antigen-presenting cells and manipulating alloreactivity.
    Micklethwaite KP; Garvin FM; Kariotis MR; Yee LL; Hansen AM; Antonenas V; Sartor MM; Turtle CJ; Gottlieb DJ
    Cytotherapy; 2009; 11(2):218-28. PubMed ID: 19242837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of large numbers of highly purified lymphocytes and monocytes with a modified centrifugal elutriation technique.
    Figdor CG; Bont WS; De Vries JE; Van Es WL
    J Immunol Methods; 1981; 40(3):275-88. PubMed ID: 7252163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of monocytes from leukapheretic products for large-scale GMP-grade generation of cytomegalovirus-specific T-cell lines by means of an automated elutriation device.
    Perseghin P; D'Amico G; Dander E; Gaipa G; Dassi M; Biagi E; Biondi A
    Transfusion; 2008 Aug; 48(8):1644-9. PubMed ID: 18513258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enrichment of circulating tumor cells from a large blood volume using leukapheresis and elutriation: proof of concept.
    Eifler RL; Lind J; Falkenhagen D; Weber V; Fischer MB; Zeillinger R
    Cytometry B Clin Cytom; 2011 Mar; 80(2):100-11. PubMed ID: 20954267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First comparative evaluation of a new leukapheresis technology in non-cytokine-stimulated donors.
    Steininger PA; Strasser EF; Weiss D; Achenbach S; Zimmermann R; Eckstein R
    Vox Sang; 2014 Apr; 106(3):248-55. PubMed ID: 24152115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized processing of growth factor mobilized peripheral blood CD34+ products by counterflow centrifugal elutriation.
    Tran CA; Torres-Coronado M; Gardner A; Gu A; Vu H; Rao A; Cao LF; Ahmed A; Digiusto D
    Stem Cells Transl Med; 2012 May; 1(5):422-9. PubMed ID: 23197821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE). I. Characterization of B-lymphocyte-, T-lymphocyte-, and monocyte-enriched fractions by flow cytometric analysis.
    Wahl LM; Katona IM; Wilder RL; Winter CC; Haraoui B; Scher I; Wahl SM
    Cell Immunol; 1984 May; 85(2):373-83. PubMed ID: 6232002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enrichment of oncolytic cells for adoptive therapy using centrifugal elutriation.
    Savary CA; Lotzová E; Lichtiger B; Freireich EJ
    J Clin Lab Immunol; 1990 Jul; 32(3):123-9. PubMed ID: 1966948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte isolation by counterflow centrifugation-elutriation of canine blood obtained by continuous-flow centrifugation leukapheresis.
    Jemionek JF; Contreras TJ; French JE; Shields LJ
    Exp Hematol; 1978 Nov; 6(10):801-8. PubMed ID: 744203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
    Babatz J; Röllig C; Oelschlägel U; Zhao S; Ehninger G; Schmitz M; Bornhäuser M
    J Hematother Stem Cell Res; 2003 Oct; 12(5):515-23. PubMed ID: 14594508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of monocytes from whole blood-derived buffy coats by continuous counter-flow elutriation.
    Schwanke U; Nabereit A; Moog R
    J Clin Apher; 2006 Oct; 21(3):153-7. PubMed ID: 16395728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Closing the manufacturing process of dendritic cell vaccines transduced with adenovirus vectors.
    Gulen D; Abe F; Maas S; Reed E; Cowan K; Pirruccello S; Wisecarver J; Warkentin P; Northam M; Turken O; Coskun U; Senesac J; Talmadge JE
    Int Immunopharmacol; 2008 Dec; 8(13-14):1728-36. PubMed ID: 18793758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.